Recursion Pharmaceuticals (RXRX) Short Interest Ratio & Short Volume

Recursion Pharmaceuticals logo
$3.23 +0.12 (+3.86%)
Closing price 04:00 PM Eastern
Extended Trading
$3.20 -0.02 (-0.77%)
As of 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Recursion Pharmaceuticals Short Interest Overview

As of May 29, 2026, Recursion Pharmaceuticals (RXRX) had a short interest of 164.34 million shares sold short, representing 33.87% of the public float. This marks a -10.90% decrease in short interest since the prior report. The short interest ratio (days to cover) is 8.0, meaning it would take 8.0 days of the average trading volume of 17.53 million shares to cover all short positions.

Current Short Interest
164,340,230 shares
Previous Short Interest
184,440,829 shares
Change Vs. Previous Month
-10.90%
Dollar Volume Sold Short
$589.98 million
Short Interest Ratio
8.0 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
529,910,000 shares
Short Percent of Float
33.87%
Today's Trading Volume
24,747,184 shares
Average Trading Volume
17,529,357 shares
Today's Volume Vs. Average
141%
Short Selling Recursion Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

RXRX Short Interest Over Time

RXRX Days to Cover Over Time

RXRX Percentage of Float Shorted Over Time

Recursion Pharmaceuticals Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/2026164,340,230 shares $589.98 million -10.9%33.9%8.02 $3.59
5/15/2026184,440,829 shares $540.41 million +7.7%38.0%13.28 $2.93
4/30/2026171,321,811 shares $592.77 million -1.8%35.3%14.78 $3.46
4/15/2026174,397,876 shares $653.99 million +0.3%35.3%17.12 $3.75
3/31/2026173,926,845 shares $533.09 million -0.1%36.0%12.29 $3.07
3/13/2026174,136,749 shares $595.55 million +3.3%36.1%12.67 $3.42
2/27/2026168,516,142 shares $618.45 million -2.7%34.9%8.86 $3.67
2/13/2026173,170,498 shares $604.37 million +4.6%36.4%7.63 $3.49
1/30/2026165,548,707 shares $693.65 million +1.3%34.8%7.95 $4.19
1/15/2026163,381,460 shares $758.09 million -1.4%34.3%8.15 $4.64
12/31/2025165,731,774 shares $677.84 million +7.8%34.8%6.14 $4.09
12/15/2025153,738,758 shares $645.70 million +1.2%32.3%8.22 $4.20
11/28/2025151,875,532 shares $702.42 million +4.3%31.9%6.48 $4.63
11/14/2025145,661,814 shares $603.04 million +13.3%36.6%3.89 $4.14
10/31/2025128,586,047 shares $709.79 million +1.8%32.3%1.99 $5.52
10/15/2025126,350,000 shares $857.92 million -5.3%38.0%3.4 $6.79
9/30/2025133,410,000 shares $651.04 million +1.0%40.1%4.8 $4.88
9/15/2025132,040,000 shares $629.83 million +6.4%39.7%5.3 $4.77
8/31/2025124,080,000 shares $583.18 million +1.5%37.3%4.9 $4.70
8/15/2025122,220,000 shares $705.21 million +4.0%36.8%4.5 $5.77
7/31/2025117,540,000 shares $699.36 million +1.7%35.4%4.2 $5.95
7/15/2025115,530,000 shares $603.07 million -1.6%35.0%4.2 $5.22
6/30/2025117,410,000 shares $594.09 million -2.2%35.5%4.5 $5.06
6/15/2025120,080,000 shares $590.79 million +10.1%38.6%5 $4.92
5/31/2025109,030,000 shares $457.93 million +4.6%35.1%4.9 $4.20
5/15/2025104,220,000 shares $442.94 million +11.9%33.5%4.9 $4.25
4/30/202593,120,000 shares $520.54 million -1.5%30.3%3.7 $5.59
4/15/202594,520,000 shares $533.09 million +6.8%30.9%3.8 $5.64
3/31/202588,500,000 shares $468.17 million +2.4%28.9%3.8 $5.29
3/15/202586,420,000 shares $548.77 million +7.1%28.3%3.8 $6.35
2/28/202580,720,000 shares $606.21 million +7.0%26.4%3.5 $7.51
2/15/202575,450,000 shares $794.49 million +18.4%25.4%3.5 $10.53
1/31/202563,750,000 shares $461.55 million -6.1%19.7%3.9 $7.24
1/15/202567,860,000 shares $435.66 million -8.0%21.0%5.2 $6.42
12/31/202473,740,000 shares $498.48 million +9.9%22.8%6.6 $6.76
12/15/202467,100,000 shares $466.35 million -1.1%20.7%7.2 $6.95
11/30/202467,850,000 shares $479.70 million +5.1%22.4%8.8 $7.07
11/15/202464,570,000 shares $398.72 million +3.4%21.3%10.9 $6.18
10/31/202462,430,000 shares $394.56 million +5.0%28.0%12.7 $6.32
10/15/202459,440,000 shares $396.46 million -5.0%26.2%12.2 $6.67
Trump is positioned. Elon lights the fuse. (Ad)

Three of Trump's biggest power plays are landing at the same time. One... the Clarity Act, racing toward a July 4th signature that ends crypto's regulatory limbo for good. Two... America's 250th birthday, with the White House determined to crown us the crypto capital of the world. Three... a winding-down Iran war that's dragging oil prices down and pulling fear out of the market. Any one of these could move crypto on its own. All three at once? That's the kind of setup that doesn't come around often.tc pixel

9/30/202462,580,000 shares $412.40 million +5.8%27.9%12.3 $6.59
9/15/202459,160,000 shares $388.68 million +5.6%26.5%10.2 $6.57
8/31/202456,030,000 shares $407.90 million +3.5%26.0%9.9 $7.28
8/15/202454,150,000 shares $362.26 million +7.5%25.1%9.6 $6.69
7/31/202450,370,000 shares $413.03 million +2.1%24.7%8.8 $8.20
7/15/202449,330,000 shares $404.51 million +9.8%24.8%8.9 $8.20
6/30/202444,920,000 shares $336.90 million 0.0%23.6%8.5 $7.50
6/15/202444,930,000 shares $416.05 million +3.0%26.5%9.6 $9.26
5/31/202443,640,000 shares $361.34 million +3.0%26.7%8.6 $8.28
5/15/202442,370,000 shares $424.12 million +4.6%26.1%7.3 $10.01
4/30/202440,500,000 shares $316.71 million +4.7%25.0%6.5 $7.82
4/15/202438,700,000 shares $301.47 million -2.7%26.4%6.2 $7.79
3/31/202439,760,000 shares $396.41 million -8.6%27.1%5.7 $9.97
3/15/202443,520,000 shares $488.29 million +1.6%29.7%6.2 $11.22
2/29/202442,820,000 shares $576.36 million +12.0%29.2%6.4 $13.46
2/15/202438,240,000 shares $475.32 million -0.1%26.1%6 $12.43
1/31/202438,270,000 shares $360.12 million +0.5%25.2%7.1 $9.41
1/15/202438,090,000 shares $425.08 million +2.8%25.1%7.3 $11.16
12/31/202337,040,000 shares $365.21 million +0.1%24.4%8.1 $9.86
12/15/202337,020,000 shares $359.09 million +3.1%24.4%9.2 $9.70
11/30/202335,920,000 shares $246.05 million +1.2%23.9%9.1 $6.85
11/15/202335,500,000 shares $254.89 million +7.4%23.6%9.6 $7.18
10/31/202333,050,000 shares $174.50 million +3.8%23.9%9.3 $5.28
10/15/202331,850,000 shares $203.20 million +3.6%23.0%8.5 $6.38
9/30/202330,750,000 shares $235.24 million +26.3%22.2%4.6 $7.65
9/15/202324,340,000 shares $208.59 million +5.6%17.7%3.8 $8.57
8/31/202323,040,000 shares $200.45 million +11.8%17.6%3.8 $8.70
8/15/202320,610,000 shares $189.41 million +4.8%15.8%3.3 $9.19
7/31/202319,670,000 shares $277.74 million -0.3%16.6%3.4 $14.12
7/15/202319,720,000 shares $234.67 million +6.4%16.7%3.8 $11.90
6/30/202318,540,000 shares $138.49 million -5.0%15.7%8.9 $7.47
6/15/202319,520,000 shares $181.54 million +5.7%16.5%9.7 $9.30
5/31/202318,460,000 shares $161.89 million -7.7%15.8%9.9 $8.77
5/15/202320,000,000 shares $112 million -2.2%17.3%12.4 $5.60
4/30/202320,440,000 shares $97.50 million +2.2%17.8%18.4 $4.77
4/15/202320,000,000 shares $118.80 million +0.9%17.4%19.6 $5.94
3/31/202319,830,000 shares $132.27 million +4.3%17.3%20.3 $6.67
3/15/202319,020,000 shares $142.27 million +8.1%16.6%19 $7.48
2/28/202317,600,000 shares $143.44 million +1.7%15.4%16.4 $8.15
2/15/202317,310,000 shares $146.10 million -3.1%15.2%15.3 $8.44
1/31/202317,870,000 shares $148.86 million +2.2%16.7%14.4 $8.33
1/15/202317,480,000 shares $152.08 million +4.2%15.1%14 $8.70
12/30/202216,780,000 shares $129.37 million +17.8%14.4%13.9 $7.71
12/15/202214,240,000 shares $120.61 million -4.4%12.2%11.9 $8.47
11/30/202214,890,000 shares $139.97 million -0.2%13.5%11.9 $9.40
11/15/202214,920,000 shares $176.95 million -5.6%13.6%12.8 $11.86
10/31/202215,800,000 shares $166.69 million +1.6%19.3%14.1 $10.55
10/15/202215,550,000 shares $163.12 million -3.9%18.4%14.4 $10.49
9/30/202216,180,000 shares $172.16 million +12.4%19.2%14.8 $10.64
9/15/202214,390,000 shares $188.65 million -1.4%17.1%12.2 $13.11
Trump is positioned. Elon lights the fuse. (Ad)

There's a power play almost nobody is connecting to crypto... The Iran war is winding down. And Trump's fingerprints are all over it. As the ceasefire holds, oil has already fallen roughly 20% off its highs. That fear premium that's been hanging over every market for months? It's bleeding out by the day. And when fear leaves the market... risk-on assets wake up. It's the simplest setup in the world, and it's hiding in plain sight. Cooling conflict. Cheaper energy. A calmer macro backdrop. Exactly the conditions where money rotates back into the assets with the most upside.tc pixel

8/31/202214,590,000 shares $153.34 million -7.6%17.4%14.3 $10.51
8/15/202215,790,000 shares $204.64 million -5.8%18.9%15.6 $12.96
7/31/202216,770,000 shares $141.87 million +4.9%20.2%16.6 $8.46
7/15/202215,990,000 shares $135.92 million +11.7%19.3%15.4 $8.50
6/30/202214,310,000 shares $116.48 million +3.0%17.3%13 $8.14
6/15/202213,890,000 shares $92.79 million -0.9%16.7%12.9 $6.68
5/31/202214,020,000 shares $85.80 million +3.4%17.1%12.5 $6.12
5/15/202213,560,000 shares $76.48 million -3.0%16.5%11.3 $5.64
4/30/202213,980,000 shares $86.68 million +0.4%17.1%12.1 $6.20
4/15/202213,920,000 shares $103.84 million -5.6%17.2%11.9 $7.46
3/31/202214,740,000 shares $105.54 million -8.2%16.9%12.7 $7.16
3/15/202216,060,000 shares $100.38 million -1.6%18.7%13.3 $6.25
2/28/202216,320,000 shares $178.70 million +5.0%19.0%11.1 $10.95
2/15/202215,550,000 shares $185.05 million +6.4%17.9%10.4 $11.90
1/31/202214,620,000 shares $173.10 million +5.6%16.7%9.3 $11.84
1/15/202213,840,000 shares $191.13 million +3.3%15.8%8.7 $13.81
12/31/202113,400,000 shares $229.54 million +20.8%15.3%8.5 $17.13
12/15/202111,090,000 shares $219.03 million +4.0%12.6%7.3 $19.75
11/30/202110,660,000 shares $203.82 million -2.8%12.8%9.4 $19.12
11/15/202110,970,000 shares $205.69 million -5.5%13.2%12 $18.75
10/29/202111,610,000 shares $222.33 million -10.8%14.0%15.7 $19.15
10/15/202113,010,000 shares $247.71 million +8.5%15.7%21.3 $19.04
9/30/202111,990,000 shares $275.89 million +31.9%14.5%24.4 $23.01
9/15/20219,090,000 shares $217.71 million +25.2%12.0%18.9 $23.95
8/31/20217,260,000 shares $183.10 million +19.0%9.6%16.5 $25.22
8/13/20216,100,000 shares $137.07 million No Change7.6%15.2 $22.47

RXRX Short Interest - Frequently Asked Questions

Short interest is the volume of Recursion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 29th, traders have sold 164,340,230 shares of RXRX short. 33.87% of Recursion Pharmaceuticals' shares are currently sold short. Learn More on Recursion Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RXRX shares currently have a short interest ratio of 8.0. Learn More on Recursion Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 33.87% of Recursion Pharmaceuticals' floating shares are currently sold short.

Recursion Pharmaceuticals saw a drop in short interest during the month of May. As of May 29th, there was short interest totaling 164,340,230 shares, a drop of 10.9% from the previous total of 184,440,829 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

33.87% of Recursion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Recursion Pharmaceuticals: Qiagen N.V. (3.07%), ImmunityBio, Inc. (41.34%), Nuvalent, Inc. (6.99%), Praxis Precision Medicines, Inc. (13.46%), Vaxcyte, Inc. (10.37%), Spyre Therapeutics, Inc. (17.25%), Immunovant, Inc. (9.53%), Lantheus Holdings, Inc. (8.56%), Protagonist Therapeutics, Inc. (12.15%), Legend Biotech Corporation Sponsored ADR (6.77%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling RXRX is an investing strategy that aims to generate trading profit from Recursion Pharmaceuticals as its price is falling. RXRX shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Recursion Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RXRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXRX, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like RXRX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:RXRX) was last updated on 6/18/2026 by MarketBeat.com Staff.
From Our Partners